Search

everythinglearnresearchcommunity

for

Search:↓

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.

Botulinum toxin A may be an effective alternative treatment for the scalp disorder folliculitis decalvans.

Taking a probiotic supplement twice a day improved hair growth, skin hydration, and metabolic health in adults at risk of metabolic syndrome.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Folliculitis decalvans was successfully treated with doxycycline and ozenoxacin.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Psoriasis is a common skin disorder caused by immune system issues, treatable with various therapies.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Topical treatments led to hair regrowth in a man with linear morphea.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

TAF can be identified by excessive skin thickening and clogged hair follicles, helping distinguish it from similar skin conditions.

Dermoscopy is becoming essential for diagnosing skin conditions and is expected to be a standard tool for dermatologists.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

A girl with Crohn's disease developed hair loss from her medication, which improved with treatment but later returned.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Hair loss is common in IBD patients, and some medications may lower the risk.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Radiotherapy was effective for treating a large scalp plaque of Bowen's disease when other treatments failed.